Lensar (LNSR) Other Non-Current Assets (2019 - 2026)
Lensar's (LNSR) quarterly Other Non-Current Assets came in at $2.6 million in Q1 2026, up 2.95% year-on-year from $2.5 million in Q1 2025, and down 7.17% on a QoQ basis from $2.7 million in Q4 2025.
Lensar (LNSR) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 2.95% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 2.95% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 5.05% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.6 million, down from $2.7 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for LNSR reached as high as $3.1 million in Q1 2022 and fell as low as $1.8 million in Q3 2024.
- Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $2.6 million in 2026.
- Across the five-year window, Other Non-Current Assets retreated 21.1% in 2024 and surged 58.58% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $2.7 million in 2022, then decreased by 17.8% to $2.2 million in 2023, then gained by 18.49% to $2.6 million in 2024, then advanced by 5.05% to $2.7 million in 2025, then declined by 7.17% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.6 million in Q1 2026, $2.7 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 2.61 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.35 Mn |
| Jun 30, 2021 | 3.49 Mn |